Skip to main content
Earnings Labs
Cerus Corporation logo

Cerus Corporation (CERS)

NASDAQ·Healthcare·Medical - Devices

$2.07

+2.48%

Mkt Cap $430.16M

Analyst Ratings

No recent rating data.

Price Target (4 analysts)

$4.00

Range $4.00 – $4.00

Implied Upside

+93.2%

Consensus $4.00 vs current $2.07